Open AccessThe impact of device-assisted therapies on the gut microbiome in Parkinson’s disease
Author(s) -
Michal Lubomski,
Xiangnan Xu,
Andrew Holmes,
Jean Yang,
Carolyn M. Sue,
Ryan L. Davis
Publication year - 2021
Publication title -
journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.541
H-Index - 136
eISSN - 1432-1459
pISSN - 0340-5354
DOI - 10.1007/s00415-021-10657-9
Subject(s) - parkinson's disease , microbiome , medicine , neurology , disease , deep brain stimulation , gut microbiome , gut flora , bioinformatics , immunology , biology , psychiatry
Microbiome feedbacks are proposed to influence Parkinson's disease (PD) pathophysiology. A number of studies have evaluated the impact of oral medication on the gut microbiome (GM) in PD. However, the influence of PD device-assisted therapies (DATs) on the GM remains to be investigated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom